Pain, depression, and quality of life in adults with MOG-antibody-associated disease.
Susanna AsseyerEugenia HenkeCorinna TrebstMartin W HümmertBrigitte WildemannSven JariusMarius RingelsteinOrhan AktasMarc PawlitzkiMelanie KorsenLuisa KlotzNadja SiebertKlemens RuprechtJudith Bellmann-StroblKlaus-Dieter WerneckeVivien HäußlerJoachim HavlaAnna GahlenRalf GoldFriedemann PaulIngo KleiterIlya Ayzenbergnull nullPublished in: European journal of neurology (2021)
Being highly prevalent, pain and depression strongly affect QoL and ADL in MOGAD. Both conditions remain insufficiently controlled in real-life clinical practice.